PSI

Following a successful pilot in 2002, in 2003 PSI/Cambodia established an initiative to provide branded malaria treatment through private clinics, pharmacies and shops across most of rural Cambodia. By 2009 this program provided half of all malaria treatment in the country and 75% of all artesunate and mefloquine (AS/MQ) distributed. Cambodia was the first country to pilot and then scale-up the provision of subsidized ACTs in the private sector.

The PSI/Cambodia experience shows that large-scale provision of ACTs is possible through private sector channels. Ongoing supply management, greatly dependent on donor flexibility and responsiveness, and regular, focused interactions with retailers are important factors in assuring both price and quality service at the outlet level.

Read the case study here.

Related content by category
Country: Cambodia
Health Areas: Malaria